Membrane associated proteases and their inhibitors in tumour angiogenesis.
about
ADAM15 disintegrin is associated with aggressive prostate and breast cancer diseaseInflammatory breast cancer: New factors contribute to disease etiology: A reviewTransient reduction of placental angiogenesis in PAI-1-deficient miceIdentification and characterization of human archaemetzincin-1 and -2, two novel members of a family of metalloproteases widely distributed in Archaea.Tumoral and choroidal vascularization: differential cellular mechanisms involving plasminogen activator inhibitor type I.ATF3 functions as a novel tumor suppressor with prognostic significance in esophageal squamous cell carcinoma.Overexpression of proto-oncogene FBI-1 activates membrane type 1-matrix metalloproteinase in association with adverse outcome in ovarian cancersHost plasminogen activator inhibitor-1 promotes human skin carcinoma progression in a stage-dependent manner.Unimpeded skin carcinogenesis in K14-HPV16 transgenic mice deficient for plasminogen activator inhibitor.Regulation of proteinases during mouse peri-implantation development: urokinase-type plasminogen activator expression and cross talk with matrix metalloproteinase 9DNA ploidy analysis and expression of MMP-9, TIMP-2, and E-cadherin in gastric carcinoma.Perlecan modulates VEGF signaling and is essential for vascularization in endochondral bone formation.Cyclic thrombospondin-1 mimetics: grafting of a thrombospondin sequence into circular disulfide-rich frameworks to inhibit endothelial cell migration.Antiprotease therapy in cancer: hot or not?Review of the effects of anti-angiogenic compounds on the epiphyseal growth plate.The critical role of dysregulated FOXM1-PLAUR signaling in human colon cancer progression and metastasis.Expression of a disintegrin and metalloprotease (ADAM and ADAMTS) enzymes in human non-small-cell lung carcinomas (NSCLC).Membrane-anchored proteases in endothelial cell biology.Identification of VEGF-regulated genes associated with increased lung metastatic potential: functional involvement of tenascin-C in tumor growth and lung metastasis.Vascular regression and survival are differentially regulated by MT1-MMP and TIMPs in the aortic ring model of angiogenesis.Matrix metalloproteinase-2 is elevated in midtrimester amniotic fluid prior to the development of preeclampsia.Lentiviral vector-based therapy in head and neck cancer (Review)Functional and pathway enrichment analysis for integrated regulatory network of high- and low-metastatic lung cancer.Angiogenesis and Proteinases: Influence on Vascular Morphogenesis, Stabilization and Regression.Sub-megabase resolution tiling (SMRT) array-based comparative genomic hybridization profiling reveals novel gains and losses of chromosomal regions in Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma cell lines.Epigenetic control of the invasion-promoting MT1-MMP/MMP-2/TIMP-2 axis in cancer cellsAngiogenic properties of myofibroblasts isolated from normal human skin wounds.Matriptase-2 inhibits HECV motility and tubule formation in vitro and tumour angiogenesis in vivo.Involvement of inflammation, degradation, and apoptosis in a mouse model of glaucoma.Collagens, stromal cell-derived factor-1alpha and basic fibroblast growth factor increase cancer cell invasiveness in a hyaluronan hydrogel.MMP-2 silencing reduces the osteogenic transformation of fibroblasts by inhibiting the activation of the BMP/Smad pathway in ankylosing spondylitis.Unraveling the Role of Angiogenesis in Cancer Ecosystems.
P2860
Q24676359-DD2EE6A3-B64B-4B3C-ADF0-CD7DFF7437C6Q27027856-203B481E-7E63-4F00-AA77-8A1D54D1BA4DQ28510418-FBDC1D45-F64D-4520-8FA8-8B6186C05C16Q31808704-E5E6F0D7-9802-4FF5-93F4-9B93F0EFD052Q33295022-5F0BBB89-3DE4-48DA-A731-F518B8F11040Q34483678-001224C2-98F8-4241-A048-E77F0F724989Q34499040-44101B07-82E3-40E7-86AF-7C159E8D4A56Q34725029-3E0DA8DA-E12C-45A0-B72B-77E4FD7CAE48Q34887726-E88C6B8D-6270-4358-9D92-F02BF9497761Q35142158-4A4F3AF8-B4B1-4854-9F55-6A42F11CE9B0Q35784055-2100932C-46DC-47C0-BFFA-2A435C0C4049Q35923316-FF1116CD-47D1-470A-B59C-8C9E0921A762Q36321375-DE0BAC2D-89D9-4D7C-A79A-2C04C9C9E9E0Q36407244-71665E83-DE19-47EE-84C3-1F69EAE1ECCCQ36421314-AC6E1CDB-6876-4BDB-B104-A196D0559FB3Q36510909-F586DF8A-347F-41B1-A394-639B6B01D5F3Q36613950-2FB6F349-F5DC-4669-8E62-BFD81FB39927Q36940312-C517D462-9522-49B4-ABB7-F59C03F498EAQ37243488-D8453441-DF4B-4C8A-8223-BBDB730F1397Q37297991-C270B696-D4B4-4ED1-934C-4787EF3E57EDQ37322424-7F0220BC-A9C8-444A-B816-1ACBC784DE9BQ38172153-96BA7386-B471-4E45-9D64-885E141A1FADQ39090210-4A4E222D-11E6-436F-A67B-54B036CEB4C3Q39367074-577DD71B-8D55-4F41-A409-0F97B9FBE481Q40027786-5E6480FE-2BC2-4243-9797-201968921116Q41851580-16A2858C-2818-47E2-8289-D8C87FB1DBABQ44853553-9C369830-3136-4CC8-BA99-E7657AEB7D1FQ44899123-043F87B1-A9F5-4F33-8A84-845E4FB9533FQ46572704-C089BE15-E4C4-4775-9CCC-F54D90E0FCDEQ46705812-29114BB7-CE11-41B9-B847-26C7DC1626B0Q49677530-04F542F1-A8B0-40A3-A08A-92B24FE6ED29Q55690308-EF2844FE-B6C8-4546-83C8-8E1FAC31ABAB
P2860
Membrane associated proteases and their inhibitors in tumour angiogenesis.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Membrane associated proteases and their inhibitors in tumour angiogenesis.
@ast
Membrane associated proteases and their inhibitors in tumour angiogenesis.
@en
type
label
Membrane associated proteases and their inhibitors in tumour angiogenesis.
@ast
Membrane associated proteases and their inhibitors in tumour angiogenesis.
@en
prefLabel
Membrane associated proteases and their inhibitors in tumour angiogenesis.
@ast
Membrane associated proteases and their inhibitors in tumour angiogenesis.
@en
P2093
P2860
P356
P1476
Membrane associated proteases and their inhibitors in tumour angiogenesis.
@en
P2093
C Maillard
J M Foidart
N E Sounni
V Chabottaux
P2860
P304
P356
10.1136/JCP.2003.014472
P407
P577
2004-06-01T00:00:00Z